The global Stent Market size was valued at USD 13.18 Billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 5.9% during the forecast period, reaching a value of USD 19.60 Billion by 2030.
Stent Market research report by Future Data Stats, offers a comprehensive view of the Market's historical data from 2019 to 2022, capturing trends, growth patterns, and key drivers. It establishes 2023 as the base year, analyzing the Market landscape, consumer behavior, competition, and regulations. Additionally, the report presents a well-researched forecast period from 2024 to 2032, leveraging data analysis techniques to project the Market's growth trajectory, emerging opportunities, and anticipated challenges.
MARKET OVERVIEW:
A stent is a tiny tube typically made of metal or plastic that doctors insert into narrowed or blocked blood vessels to keep them open. It's commonly used to treat conditions like coronary artery disease, where plaque buildup restricts blood flow to the heart. During a minimally invasive procedure called angioplasty, the stent is inserted into the narrowed artery and then expanded, acting as a scaffold to support the vessel walls and maintain proper blood flow. Stents can also be used in other parts of the body, such as the kidneys or the legs, to treat similar blockages and improve circulation.
MARKET DYNAMICS:
The increasing prevalence of cardiovascular diseases worldwide, leading to a higher demand for stent procedures to restore proper blood flow in affected arteries. Additionally, advancements in stent technology, such as the development of drug-eluting stents that reduce the risk of restenosis, have contributed to market expansion. Moreover, rising healthcare expenditure and improving access to healthcare services in emerging economies are further fueling market growth by enabling more patients to undergo stent procedures.
The high cost associated with stent procedures, particularly in regions with limited healthcare infrastructure and resources. Additionally, concerns regarding the long-term efficacy and safety of certain types of stents, such as drug-eluting stents, may impact market adoption rates. Furthermore, regulatory challenges and stringent approval processes for new stent products pose barriers to market entry for manufacturers.
STENT MARKET SEGMENTAL ANALYSIS
BY TYPE:
Bare Metal Stents (BMS) represent a traditional yet essential segment of the market, providing mechanical support to keep narrowed arteries open without the use of drug coatings. Meanwhile, Drug-Eluting Stents (DES) have gained prominence due to their ability to release medication over time, reducing the risk of restenosis and improving long-term outcomes for patients undergoing coronary interventions.
Another emerging segment within the stent market is Bioresorbable Vascular Scaffold (BVS) Stents, offering a novel approach to coronary artery treatment. These stents are designed to gradually dissolve and be absorbed by the body over time, eliminating the need for a permanent implant and potentially reducing long-term complications associated with traditional stents. The introduction of BVS stents has sparked interest among clinicians and patients alike, presenting new opportunities for improved patient care and outcomes.
While each type of stent has its advantages and applications, market dynamics such as technological advancements, regulatory considerations, and shifting healthcare landscapes play pivotal roles in determining their adoption and market share. Manufacturers continuously innovate to enhance the performance and safety profiles of stents, driving competition and diversification within the market. Moreover, increasing prevalence of cardiovascular diseases globally, coupled with aging populations and lifestyle changes, sustains demand for stent procedures and fuels market growth.
BY APPLICATION:
Coronary Artery Disease (CAD) stands as one of the primary drivers of the stent market, accounting for a significant portion of stent procedures worldwide. Stents are frequently used in the treatment of CAD to open narrowed or blocked coronary arteries, restoring blood flow to the heart muscle and alleviating symptoms such as chest pain and shortness of breath. As the prevalence of CAD continues to rise globally, fueled by factors like sedentary lifestyles and poor dietary habits, the demand for coronary stents remains robust.
Peripheral Artery Disease (PAD) represents another key application area within the stent market, addressing blockages in arteries outside the heart, typically in the legs and arms. Stents play a vital role in managing PAD by improving blood flow to affected limbs, relieving symptoms such as pain, numbness, and cramping, and reducing the risk of complications such as limb amputation. With an aging population and increasing rates of conditions like diabetes and obesity, the incidence of PAD is expected to escalate, driving the demand for peripheral stents and sustaining market growth.
Additionally, stents find applications in treating Carotid Artery Disease, a condition characterized by the narrowing of the carotid arteries in the neck, which can lead to strokes if left untreated. Carotid stenting is employed as an alternative to traditional surgical procedures to prevent strokes by opening narrowed arteries and improving blood flow to the brain. Beyond these primary applications, stents are also utilized in various other medical contexts, including the treatment of bile duct strictures, ureteral obstructions, and esophageal strictures, among others, underscoring their versatility and significance in modern healthcare.
BY MATERIAL:
Metal stents, comprising materials such as stainless steel, cobalt-chromium, and nitinol, have been a cornerstone in interventional cardiology for decades. Their robustness and mechanical strength make them suitable for providing structural support to narrowed arteries, particularly in coronary interventions. Metal stents continue to be widely utilized in clinical practice, demonstrating their enduring significance in the stent market.
Polymer-based stents represent a newer entrant in the market, leveraging materials like bioabsorbable polymers to offer unique advantages. These stents are designed to degrade over time within the body, reducing the long-term risks associated with permanent implants such as inflammation and late stent thrombosis. Polymer stents also provide a platform for drug delivery, enabling the controlled release of medications to prevent restenosis and promote healing. Their biocompatibility and tailored degradation profiles position polymer stents as a promising avenue for innovation and growth within the stent market.
Beyond metal and polymer, other materials such as biodegradable metals and hybrid constructs are emerging as areas of interest for stent development. Biodegradable metal stents offer the potential for temporary support while promoting tissue healing, gradually resorbing into the body once their function is no longer needed. Hybrid stent designs combine multiple materials to optimize mechanical properties and biological responses, aiming to enhance stent performance and patient outcomes.
BY END USER:
Hospitals stand as the cornerstone of stent procedures, providing comprehensive medical services and specialized facilities for cardiovascular interventions. With state-of-the-art catheterization labs and skilled medical personnel, hospitals serve as primary centers for performing stent placements, catering to patients with a wide range of cardiac conditions.
Cardiac centers represent another significant segment within the stent market, specializing in the diagnosis and treatment of cardiovascular diseases. These centers often feature specialized cardiac catheterization laboratories equipped with advanced imaging technology and interventional tools, facilitating precise stent placements and optimal patient outcomes. By focusing exclusively on cardiac care, these centers play a crucial role in driving innovation and best practices in stent procedures, serving as hubs for clinical research and professional development.
Ambulatory Surgical Centers (ASCs) have emerged as an alternative setting for stent procedures, offering convenience and cost-effectiveness for patients requiring outpatient interventions. These facilities provide a range of surgical services in a less intimidating and more patient-friendly environment compared to traditional hospital settings.
REGIONAL ANALYSIS:
North America commands a significant share of the global stent market, driven by factors such as high healthcare expenditure, advanced healthcare infrastructure, and a large patient population with cardiovascular diseases. Moreover, continuous technological advancements and favorable reimbursement policies contribute to the widespread adoption of stent procedures in the region. In Europe, robust regulatory frameworks and emphasis on evidence-based medicine shape the stent market landscape. Countries like Germany, France, and the United Kingdom lead in stent adoption, supported by well-established healthcare systems and proactive initiatives for cardiovascular disease management.
Asia Pacific emerges as a rapidly growing market for stents, propelled by the rising prevalence of cardiovascular diseases and improving healthcare infrastructure across countries such as China, India, and Japan. Increasing awareness about the importance of early diagnosis and intervention, coupled with expanding access to healthcare services, fuels market expansion in the region.
KEY MARKET PLAYERS:
- Medtronic plc
- Abbott Laboratories
- Boston Scientific Corporation
- Terumo Corporation
- B. Braun Melsungen AG
- Johnson & Johnson
- Biotronik SE & Co. KG
- Cook Medical LLC
- C.R. Bard, Inc. (acquired by Becton, Dickinson and Company)
- MicroPort Scientific Corporation
- Meril Life Sciences Pvt. Ltd.
- Cardinal Health, Inc.
- W. L. Gore & Associates, Inc.
- Lifetech Scientific (Shenzhen) Co., Ltd.
- Vascular Concepts Limited (Vascular Concepts Pvt. Ltd.)
- Translumina GmbH
- Elixir Medical Corporation
- Opto Circuits (India) Ltd.
- AlviMedica Medical Technologies Inc.
- Hexacath
- Arterius Limited
- Amaranth Medical, Inc.
- Medinol Ltd.
- OrbusNeich Medical Company Limited
- STENTYS SA
Table of Contents
Introduction
Executive Summary
Market Overview
Market Dynamics
Drivers
Restraints
Opportunities
Challenges
Stent Market Segmentation
By Type
By Application
By Material
By End User
By Region
Competitive Landscape
Company Profiles
Investment Analysis
Future Outlook
Appendix
Stent Market Segmentation
By Type:
- Bare Metal Stents (BMS)
- Drug-Eluting Stents (DES)
- Bioresorbable Vascular Scaffold (BVS) Stents
By Application:
- Coronary Artery Disease (CAD)
- Peripheral Artery Disease (PAD)
- Carotid Artery Disease
- Others
By Material:
- Metal
- Polymer
- Others
By End User:
- Hospitals
- Cardiac Centers
- Ambulatory Surgical Centers
- Others
By Geography:
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Reasons to Buy this Report
- Comprehensive Insights: Market research reports provide in-depth and comprehensive insights into various industries, markets, and sectors. These reports are prepared after extensive data collection, analysis, and interpretation, offering you valuable information and a clear understanding of market trends, dynamics, and opportunities.
- Future Predictions: Market research reports often include future data statistics, forecasts, and predictions. These predictions are based on rigorous analysis and modeling techniques, taking into account various factors such as market growth drivers, challenges, and emerging trends. By accessing these future data stats, you can make informed decisions and develop strategies that align with the projected market scenarios.
- Industry Analysis: Market research reports offer detailed industry analysis, including factors such as market size, market share, competitive landscape, and key players. These reports provide an overview of the industry's current status, growth potential, and competitive dynamics, enabling you to identify lucrative opportunities and stay ahead of the competition.
- Market Trends and Opportunities: By purchasing market research reports, you gain access to up-to-date information on market trends and emerging opportunities. These reports highlight the latest consumer preferences, technological advancements, regulatory changes, and other influential factors shaping the market landscape. Keeping track of these trends helps you identify potential growth areas and adapt your business strategies accordingly.
- Risk Mitigation: Investing in a market research report can help mitigate risks associated with market uncertainties. The reports provide insights into potential risks, challenges, and barriers to entry in specific markets or industries. With this knowledge, you can develop risk mitigation strategies, anticipate market fluctuations, and make informed decisions to minimize potential losses.
- Investment Decision Support: Market research reports are valuable tools for investors, venture capitalists, and financial institutions. These reports provide reliable and data-driven information that aids in investment decision-making processes. By analyzing market research reports, investors can evaluate the market potential, assess the feasibility of investment opportunities, and gauge the expected returns on investment.
- Product Development and Innovation: Market research reports offer insights into consumer preferences, needs, and demands. This information can be leveraged for product development and innovation. By understanding the market dynamics and consumer behavior, you can tailor your products or services to meet the evolving needs of your target audience, leading to enhanced customer satisfaction and market success.
- Strategic Planning: Market research reports serve as a foundation for strategic planning. They provide a comprehensive overview of the market landscape, competitive positioning, and growth potential. With this knowledge, you can develop effective business strategies, set realistic goals, and allocate resources efficiently. Strategic planning based on accurate market research helps optimize your operations and improve your chances of success.
- Market Entry and Expansion: For businesses looking to enter new markets or expand their existing operations, market research reports are indispensable. These reports provide insights into market dynamics, consumer behavior, regulatory frameworks, and competitive landscapes specific to the target markets. This information helps you assess the feasibility of market entry, identify potential obstacles, and develop market entry strategies that increase your chances of success.
- Evidence-Based Decision Making: Market research reports provide evidence-based data and analysis, enabling you to make informed decisions. Rather than relying on assumptions or guesswork, you can base your decisions on reliable information and market insights. Evidence-based decision making reduces the risk of costly mistakes and increases the likelihood of achieving your business objectives.
RESEARCH METHODOLOGY
With a collective industry experience of about 70 years of analysts and experts, Future Data Stats encompasses the most infallible research methodology for its market intelligence and industry analysis. Not only does the company dig deep into the innermost levels of the market, but also examines the minutest details for its market estimates and forecasts.
This approach helps build a greater market-specific view of size, shape, and industry trends within each industry segment. Various industry trends and real-time developments are factored into identifying key growth factors and the future course of the market. The research proceeds are the results of high-quality data, expert views & analysis, and valuable independent opinions. The research process is designed to deliver a balanced view of the global markets and allows stakeholders to make informed decisions, to attain their highest growth objectives.
Future Data Stats offers its clients exhaustive research and analysis, based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models distill the data & statistics and enhance the accuracy of our recommendations and advice.
With Future Data Stats calibrated research process and 360° data-evaluation methodology, the clients receive:
- Consistent, valuable, robust, and actionable data & analysis that can easily be referenced for strategic business planning
- Technologically sophisticated and reliable insights through a well-audited and veracious research methodology
- Sovereign research proceeds that present a tangible depiction of the marketplace
With this strong methodology, Future Data Stats ensures that its research and analysis is most reliable and guarantees sound business planning.
The research methodology of the global market involves extensive primary and secondary research. Primary research includes about 24 hours of interviews and discussions with a wide range of stakeholders that include upstream and downstream participants. Primary research typically is a bulk of our research efforts, coherently supported by extensive secondary research. Over 3000 product literature, industry releases, annual reports, and other such documents of key industry participants have been reviewed to obtain a better market understanding and gain enhanced competitive intelligence. In addition, authentic industry journals, trade associations’ releases, and government websites have also been reviewed to generate high-value industry insights.
Primary Research:
|
Primary Research
|
Desk Research
|
Company Analysis
|
|
• Identify key opinion leaders • Questionnaire design • In-depth Interviews • Coverage across the value chain
|
• Company Website • Company Annual Reports • Paid Databases • Financial Reports
|
• Market Participants • Key Strengths • Product Portfolio • Mapping as per Value Chain • Key focus segment
|
Primary research efforts include reaching out to participants through emails, telephonic conversations, referrals, and professional corporate relations with various companies that make way for greater flexibility in reaching out to industry participants and commentators for interviews and discussions.
The aforementioned helps to:
- Validate and improve data quality and strengthen the research proceeds
- Develop a market understanding and expertise
- Supply authentic information about the market size, share, growth, and forecasts
The primary research interview and discussion panels comprise experienced industry personnel.
These participants include, but are not limited to:
- Chief executives and VPs of leading corporations specific to an industry
- Product and sales managers or country heads; channel partners & top-level distributors; banking, investments, and valuation experts
- Key opinion leaders (KOLs)
Secondary Research:
A broad array of industry sources for the secondary research typically includes, but is not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for a competitive scenario and shape of the industry
- Patent and regulatory databases to understand technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles, web-casts, and other related releases to evaluate the market
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
|
PRIMARY SOURCES |
DATA SOURCES |
|
• Top executives of end-use industries • C-level executives of the leading Parenteral Nutrition companies • Sales manager and regional sales manager of the Parenteral Nutrition companies • Industry Consultants • Distributors/Suppliers
|
• Annual Reports • Presentations • Company Websites • Press Releases • News Articles • Government Agencies’ Publications • Industry Publications • Paid Databases
|
Analyst Tools and Models:
|
BOTTOM-UP APPROACH |
TOP-DOWN APPROACH |
|
· Arriving at · Arriving at · Market Share · Key Market Players |
· Key Market Players · Market Share · Arriving at · Arriving at |
Stent Market Dynamic Factors
Drivers:
- Increasing prevalence of cardiovascular diseases globally.
- Technological advancements in stent design and materials.
- Rising healthcare expenditure and improving access to healthcare services.
- Growing demand for minimally invasive procedures.
Restraints:
- High cost associated with stent procedures.
- Concerns regarding long-term efficacy and safety of certain stent types.
- Regulatory challenges and stringent approval processes.
- Limited healthcare infrastructure in some regions.
Opportunities:
- Innovation in stent technology to address unmet medical needs.
- Expansion into emerging markets with growing healthcare needs.
- Development of bioresorbable stents and hybrid constructs.
- Strategic collaborations and partnerships for market expansion.
Challenges:
- Economic volatility impacting market growth.
- Disparities in healthcare infrastructure and access.
- Competition from alternative treatment options.
- Addressing patient and physician concerns about stent safety and efficacy.
Frequently Asked Questions
